| Literature DB >> 32779002 |
Samira Davalbhakta1, Shailesh Advani2, Shobhit Kumar3, Vishwesh Agarwal4, Samruddhi Bhoyar5, Elizabeth Fedirko5, Durga Prasanna Misra6, Ashish Goel7, Latika Gupta8,9, Vikas Agarwal6.
Abstract
The global impact of COVID-19 pandemic has led to a rapid development and utilization of mobile health applications. These are addressing the unmet needs of healthcare and public health system including contact tracing, health information dissemination, symptom checking and providing tools for training healthcare providers. Here we provide an overview of mobile applications being currently utilized for COVID-19 and their assessment using the Mobile Application Rating Scale. We performed a systematic review of the literature and mobile platforms to assess mobile applications currently utilized for COVID-19, and a quality assessment of these applications using the Mobile Application Rating Scale (MARS) for overall quality, Engagement, Functionality, Aesthetics, and Information. Finally, we provide an overview of the key salient features that should be included in mobile applications being developed for future use. Our search identified 63 apps that are currently being used for COVID-19. Of these, 25 were selected from the Google play store and Apple App store in India, and 19 each from the UK and US. 18 apps were developed for sharing up to date information on COVID-19, and 8 were used for contact tracing while 9 apps showed features of both. On MARS Scale, overall scores ranged from 2.4 to 4.8 with apps scoring high in areas of functionality and lower in Engagement. Future steps should involve developing and testing of mobile applications using assessment tools like the MARS scale and the study of their impact on health behaviours and outcomes.Entities:
Keywords: COVID-19; Contact tracing; Mobile application rating scale; Pandemic; Smartphone application
Mesh:
Year: 2020 PMID: 32779002 PMCID: PMC7417101 DOI: 10.1007/s10916-020-01633-3
Source DB: PubMed Journal: J Med Syst ISSN: 0148-5598 Impact factor: 4.460
Fig. 1a PRISMA- Mobile app search. b PRISMA- Literature search
Fig. 2MARS structure
Fig. 3Map of country of origin
App quality ratings
| App quality ratings= | App subjective ratings= | App specific ratings= | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AppName: | Categories | Countr-y | A: Engagement Mean Score = | B: Functionality Mean Score = | C: Aesthetics Mean Score = | D: Information Mean Score = | App quality mean Score = | Subjective= | Awarenes-s | Knowledg-e | Attitude-s | Intentio-n to change | Help seeking behaviour-r | Behaviou-r change |
| Jaano | Information D + Tracking | Asia | 3.4 | 5 | 3 | 3.4 | 3.63 | 3 | 4 | 4 | 4 | 3 | 3 | 3 |
| Covid Locator | Information D + Tracking | Asia | 3.6 | 5 | 4.3 | 3.4 | 4.03 | 3.5 | 3 | 3 | 3 | 3 | 4 | 3 |
| COVA Punjab | Information D + Tracking | Asia | 3.6 | 5 | 4.3 | 3.8 | 4.14 | 3.5 | 3 | 2 | 2 | 3 | 2 | 3 |
| Corona Watch | Information D + Tracking | Asia | 3 | 5 | 3.6 | 4 | 3.83 | 3.2 | 3 | 1 | 3 | 2 | 4 | 3 |
| Aarogya Setu | Information D + Tracking | Asia | 3.6 | 5 | 4.3 | 4.1 | 4.22 | 3.75 | 1 | 4 | 2 | 2 | 2 | 2 |
| MapmyIndia Move: Maps, Navigation & Tracking | Information D + Tracking | Asia | 3.4 | 5 | 4.6 | 1.8 | 3.44 | 1.2 | 3 | 2 | 1 | 1 | 2 | 1 |
| T COVID’19 | Information D + Tracking | Asia | 4.2 | 5 | 5 | 3.8 | 4.47 | 3.5 | 3 | 4 | 3 | 3 | 3 | 3 |
| Odisha Covid Dashboard | Information D + Tracking | Asia | 3.8 | 5 | 5 | 3.4 | 4.24 | 3.5 | 3 | 3 | 3 | 3 | 3 | 3 |
| Kavach | Information D + Tracking | Asia | 4 | 5 | 4.6 | 3.8 | 4.32 | 3.5 | 3 | 4 | 3 | 3 | 4 | 4 |
| Niramaya | Information d + check symptoms | Asia | 3.2 | 5 | 4.3 | 2.7 | 3.69 | 2.5 | 3 | 3 | 3 | 3 | 3 | 3 |
| Canada COVID-19 | Information d + check symptoms | North America | 3.6 | 3.75 | 4.33 | 4.6 | 4.05 | 3.25 | 4 | 5 | 4 | 4 | 5 | 4 |
| BC COVID-19 Support | Information d + check symptoms | North America | 3.4 | 3.75 | 3.33 | 4.4 | 3.70 | 3.5 | 4 | 4 | 5 | 4 | 4 | 4 |
| Ask NHS | Information d + check symptoms | Europe | 3.8 | 4.5 | 4.33 | 4.5 | 4.27 | 4.75 | 4 | 5 | 4 | 4 | 5 | 4 |
| COVID-19 Gov PK | Information d + check symptoms | Asia | 3.2 | 4 | 3.33 | 3.8 | 3.57 | 3.5 | 4 | 4 | 3 | 4 | 4 | 2 |
| NHS24:Covid-19 | Information d + check symptoms | Europe | 3 | 5 | 4.67 | 4.75 | 4.27 | 4 | 5 | 5 | 4 | 3 | 5 | 4 |
| CoVive: your COVID-19 app | Information d + check symptoms | Europe | 3.4 | 5 | 4.6 | 4.5 | 4.33 | 3 | 3 | 5 | 4 | 2 | 4 | 2 |
| Apollo COVID-19 | Information d + check symptoms | North America | 2.4 | 4.75 | 4 | 3.5 | 3.55 | 2 | 4 | 4 | 2 | 2 | 4 | 2 |
| First Responder COVID-19 guide | Information d + check symptoms | North America | 5 | 4.75 | 5 | 4.4 | 4.78 | 4.48 | 3 | 4 | 3 | 4 | 4 | 3 |
| Coronavirus Australia | Information d + check symptoms | Australia | 4.2 | 4.25 | 4.7 | 4 | 4.28 | 3.86 | 3 | 4 | 4 | 3 | 4 | 3 |
| Covid-UAE | Information d + check symptoms | Asia | 5 | 5 | 5 | 4.2 | 4.79 | 4.54 | 5 | 5 | 4 | 5 | 3 | 4 |
| Apple COVID-19 | Information d + check symptoms | North America | 4.6 | 5 | 5 | 4.5 | 4.77 | 4.57 | 5 | 5 | 4 | 4 | 3 | 3 |
| Your.MD: Health Journal & AI Self-Care Assistant | Information d + check symptoms | Europe | 2.6 | 4.67 | 4 | 3.5 | 3.61 | 2.75 | 2 | 3 | 2 | 2 | 4 | 2 |
| Symptom Tracker & Medicine, Health Symptoms Diary | Information d + check symptoms | North America | 3.2 | 3.5 | 4 | 2.67 | 3.31 | 3.25 | 1 | 1 | 2 | 1 | 4 | 3 |
| WebMD: Check Symptoms, Find Doctors, & Rx Savings | Information d + check symptoms | North America | 2.8 | 4 | 4.33 | 4 | 3.73 | 3 | 3 | 4 | 4 | 2 | N/A | 3 |
| Babylon- Healthcare service | Information dissemination | Europe | 3.6 | 5 | 4.66 | 3.6 | 4.17 | 3.25 | 4 | 3 | 3 | 4 | 5 | 3 |
| MyGov | Information dissemination | Asia | 4.2 | 4 | 3 | 4.33 | 3.84 | 3.25 | 4 | 4 | 3 | 4 | 3 | 2 |
| HEALTHLYNKED COVID-19 Tracker | Information dissemination | North America | 3 | 4.5 | 3.33 | 3.6 | 3.57 | 2 | 2 | 3 | 3 | 2 | 3 | 3 |
| Trackmetic | Information dissemination | Asia | 2.2 | 5 | 3 | 2 | 2.85 | 1.2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Raj Covid Info | Information dissemination | Asia | 3.6 | 5 | 3.6 | 3.4 | 3.85 | 2.7 | 4 | 3 | 3 | 3 | 4 | 3 |
| CoronaReport - COVID-19 reports for Social Science | Information dissemination | Europe | 2 | 2.25 | 2.67 | 3.5 | 2.55 | 1 | 1 | 1 | 2 | 2 | N/A | 1 |
| Corona360 | Information dissemination | Europe | 1.6 | 3.25 | 3.33 | 2 | 2.43 | 1 | 2 | 1 | 1 | 1 | N/A | 2 |
| COVID19 Care for Media | Information dissemination | Asia | 3.2 | 4.5 | 3.67 | 4.25 | 3.87 | 3.75 | 4 | 5 | 4 | 4 | N/A | 3 |
| Pakistan’s National Action Plan for COVID-19 | Information dissemination | Asia | 1.4 | 5 | 3 | 3.5 | 2.93 | 2 | 3 | 2 | 3 | 3 | N/A | 4 |
| ECDC Threat Reports | Information dissemination | Europe | 2 | 3.75 | 2.67 | 4 | 2.99 | 1.75 | 3 | 4 | 3 | 4 | N/A | 2 |
| COVID-19! - The current spread of disease | Information dissemination | Europe | 3.4 | 4.5 | 4.33 | 4.4 | 4.13 | 3.75 | 4 | 4 | 3 | 3 | 3 | 2 |
| Relief Central | COVID-19 | Information dissemination | North America | 3.4 | 4.5 | 3.67 | 4.4 | 3.96 | 3.75 | 4 | 5 | 3 | 3 | 2 | 2 |
| Coronavirus COVID Tracker | Information dissemination | Europe | 3 | 4.5 | 4 | 4.4 | 3.93 | 2.75 | 2 | 5 | 3 | 3 | 3 | 2 |
| CoronaFACTS | Information dissemination | North America | 2.2 | 3.25 | 2.6 | 4 | 2.94 | 2 | 3 | 4 | 2 | 3 | 2 | 2 |
| Central Coast COVID-19 | Information dissemination | North America | 4 | 4 | 4.7 | 3.5 | 4.03 | 3.79 | 3 | 3 | 3 | 3 | N/A | 2 |
| Coronavirus--Covid19 | Information dissemination | Russia | 4.8 | 5 | 5 | 4.3 | 4.77 | 3.56 | 4 | 3 | 2 | 3 | 3 | 2 |
| NJ COVID 19 | Information dissemination | North America | 4.4 | 4.75 | 4.7 | 3.2 | 4.21 | 3.96 | 4 | 4 | 4 | 4 | 4 | 3 |
| CDC | Information dissemination | North America | 2.6 | 4.25 | 4.33 | 4.7 | 4.00 | 3.25 | 5 | 5 | 5 | 3 | 5 | 4 |
| COVID-19 West Bengal Government | Contact tracing | Asia | 2.8 | 5 | 2.6 | 1.5 | 2.72 | 1.2 | 1 | 1 | 1 | 1 | 2 | 1 |
| UP Self Quarantine App | Contact tracing | Asia | 2.2 | 5 | 2.3 | 2.4 | 2.79 | 1.5 | 1 | 1 | 1 | 1 | 2 | 1 |
| COVID Symptom Tracker | Contact tracing | Europe | 2.4 | 4.5 | 3.67 | 4.33 | 3.62 | 3.5 | 2 | 1 | 2 | 2 | N/A | 4 |
| Stop Covid | Contact tracing | Europe | 2.4 | 4.75 | 3.67 | 4 | 3.60 | 2 | 2 | 1 | 1 | 2 | 3 | 4 |
| Contact Tracing | Contact tracing | North America | 2.2 | 4.75 | 2.3 | 2 | 2.63 | 1.25 | 5 | 5 | 5 | 5 | 5 | 4 |
| PatientSphere for COVID19 | Contact tracing | North America | 3.8 | 4 | 4.3 | 3.8 | 3.97 | 3.68 | 3 | 3 | 2 | 3 | 3 | 2 |
| 1-Check COVID | Contact tracing | North America | 4 | 5 | 4.7 | 4.8 | 4.61 | 4.45 | 3 | 5 | 4 | 5 | 5 | 4 |
| Care19 | Contact tracing | North America | 3.2 | 4 | 4.3 | 3.2 | 3.64 | 3.34 | 2 | 1 | 3 | 1 | N/A | 4 |
| Hustle-Serve Your Community | Service apps (Deivery) + Raise funds | North America | 3.4 | 5 | 4.7 | 4 | 4.23 | 3.92 | 2 | 1 | 4 | 4 | 2 | 4 |
| WE DEFEAT CORONA | Service apps (Deivery) + Raise funds | Europe | 3.6 | 5 | 5 | 3.75 | 4.29 | 3.82 | 5 | 2 | 2 | 2 | N/A | 1 |
| Disinfection Checklist COVID19 | Disinfection check | North America | 3.8 | 2.5 | 4.3 | 3.3 | 3.41 | 2.87 | 1 | 2 | 4 | 2 | N/A | 3 |
| Osler COVID Learning Centre | HCW training | Australia | 2.8 | 3.75 | 4 | 4.2 | 3.64 | 2.5 | 4 | 4 | 3 | 3 | N/A | 4 |
| iCU Notes - a free Critical Care Medicine resource | HCW training | Europe | 2.4 | 5 | 2.3 | 2.8 | 2.96 | 3 | 3 | 4 | 3 | 2 | 2 | 1 |
| OpenWHO | HCW training | Europe | 3 | 5 | 3 | 2.8 | 3.35 | 2 | 4 | 4 | 2 | 2 | 2 | 2 |
| Test Yourself Puducherry | Self symptom checker | Asia | 2.6 | 5 | 3.6 | 1.8 | 3.03 | 1.5 | 1 | 1 | 1 | 1 | 2 | 1 |
| test yourself goa | Self symptom checker | Asia | 2.4 | 4.75 | 2.6 | 2.2 | 2.84 | 1.5 | 1 | 1 | 1 | 1 | 2 | 1 |
| Symptom Tracker: Health Mate | Self symptom checker | North America | 3 | 4 | 3.66 | 4 | 3.64 | 1.5 | 1 | 1 | 3 | 3 | 4 | 2 |
| Sentinel Monitor | Self symptom checker | North America | 3.2 | 4.75 | 3.33 | 3.75 | 3.71 | 1.75 | 1 | 2 | 4 | 3 | 5 | 3 |
| Mediktor- Symptom Checker | Self symptom checker | Europe | 4 | 4.5 | 3.3 | 3 | 3.65 | 3 | 1 | 1 | 3 | 3 | 5 | 4 |
| Corona Checker | Self symptom checker | North America | 3.2 | 5 | 4.7 | 4.4 | 4.26 | 4.16 | 5 | 3 | 3 | 5 | 5 | 4 |
| SymplCheck | Self symptom checker | Europe | 3.4 | 3.75 | 3.33 | 4 | 3.61 | 2.25 | 2 | 1 | 1 | 3 | 4 | 1 |
Literature search results
| Author and year of publication | Title | Time of data collection | Intervention or exposure | Sample size | Age distribution | Study design | Main outcome |
|---|---|---|---|---|---|---|---|
| Udugama B, March 30, 2020 | Diagnosing COVID-19: The Disease and Tools for Detection | N/A | N/A | N/A | N/A | Review article | Review of the diagnostic and surveillance technologies available for COVID-19 |
| Abeler J, | COVID-19 Contact Tracing and Data Protection Can Go Together | N/A | N/A | N/A | N/A | Descriptive | Described a contact tracing technology that processes minimum user data in order to protect privacy. |
| Yasaka TM, | Peer-to-Peer Contact Tracing: Development of a Privacy-Preserving Smartphone App | N/A | Transmission graph data structure to represent the interactions between individuals. | N/A | N/A | Descriptive | Developed a contact tracing smartphone app that respects user privacy by not collecting location information or other personal data. |
| Zamberg I, | A Mobile Health Platform to Disseminate Validated Institutional Measurements During the COVID-19 Outbreak: Utilization-Focused Evaluation Study | February 25th to March 13th, 2020 | Mobile app named “Head to Toe” for dissemination of institutional knowledge. | 125 healthcare professionals | N/A | Observational study | The use of an mHealth application was an effective tool with benefits of quick communication and daily updates during the COVID-19 outbreak in their hospital setup. |
| David Siu, Hong kong University. | Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19 | April 1, 2020 to December 31, 2021. | BIOVITALS platform- Armband+ remote monitoring + analytic platform | 200 (estimated) | N/A | Randomised trial | Primary outcomes: Time to diagnosis using RT-PCR, and time from quarantine to diagnosis. This technology can be used to remotely monitor COVID-19 patients |
| Maghdid H. | A Smartphone enabled Approach to Manage COVID-19 Lockdown and Economic Crisis | N/A | Grey literature | N/A | N/A | Descriptive | Developed a smartphone-based approach to trace the contacts for confirmed COVID-19 cases. Also created a dashboard to provide a plan for government officials on how lockdown/mass quarantine can be safely lifted. |
| Lu N. | Weathering COVID-19 Storm: Successful Control Measures of Five Asian Countries | N/A | N/A | 5 countries considered- China, Singapore, Japan, South Korea, Taiwan. | N/A | Descriptive | Described the successful control measures employed by China, Singapore, South Korea, Taiwan and Japan. Smartphone apps were used successfully by Singapore and South Korea mainly for contact tracing, alerts and self-symptom checks. |
| Whiting P | Accuracy of self-monitoring heart rate, respiratory rate and oxygen saturation in patients with symptoms suggestive of COVID infection. | April 1, 2020 | N/A | One systematic review ( | N/A | Systematic review | Identifies the best apps for HR or BP measurement in COVID-19 patients. |
| Drew D. | Rapid implementation of mobile technology for real-time epidemiology of COVID-19 | N/A | COVID-19 Symptom Tracker mobile application | 1,234,918 | Mean age = 41 (Range = 18–90 years) | Observational study | Developed a COVID-19 Symptom Tracker mobile application that was launched in the UK and the USA. This mobile application offers data on risk factors, herald symptoms, clinical outcomes, and geographical hot spots. Provided proof- of- concept for this approach. |
| Yang T. | Point-of-Care RNA-Based Diagnostic Device for COVID-19 | N/A | Diagnostic device for COVID-19 based on RNA combining paper based and LAMP assay technology that can be performed at home. | N/A | N/A | Descriptive | Proposed a combination of a paper-based POC diagnostic device and LAMP assay technology to allow home-based self-testing. A smartphone application will be used to facilitate test results recording/sharing with health professionals. |